|4Mar 11, 8:09 PM ET

Hawkins Jonathan 4

4 · Augmedix, Inc. · Filed Mar 11, 2022

Insider Transaction Report

Form 4
Period: 2022-03-10
Hawkins Jonathan
Chief Revenue Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-03-10+100,000100,000 total
    Exercise: $2.48Exp: 2032-03-10Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option is granted under the Augmedix, Inc. (the "Issuer") 2020 Equity Incentive Plan. The option will vest monthly in equal increments for four years starting on March 10, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date, and will be fully vested on March 10, 2026.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES